Search results for "marker"

showing 10 items of 3799 documents

Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma

2021

Evidence for immunologic contribution to glaucoma pathophysiology is steadily increasing in ophthalmic research. Particularly, an altered abundance of circulating autoantibodies to ocular antigens is frequently observed. Here, we report an analysis of autoantibody abundancies to selected antigens in sera of open-angle glaucoma patients, subdivided into normal-tension glaucoma (N = 31), primary open-angle glaucoma (N = 43) and pseudoexfoliation glaucoma (N = 45), vs. a non-glaucomatous control group (N = 46). Serum samples were analyzed by protein microarray, including 38 antigens. Differences in antibody levels were assessed by ANOVA. Five serological antibodies showed significantly altered…

lcsh:Immunologic diseases. Allergy0301 basic medicineMicroarraygenetic structuresautoantibodiesImmunologyProtein Array AnalysisGlaucomamedicine.disease_causeExfoliation SyndromeAutoantigensSerologyAutoimmunityPathogenesis03 medical and health sciences0302 clinical medicineAntigenmedicineHumansImmunology and AllergyOriginal Researchbiologybusiness.industryautoimmunityAutoantibodyComputational Biologybioinformaticsmedicine.diseaseimmunoproteomicseye diseasesClathrin030104 developmental biologyglaucomaCase-Control StudiesImmunology030221 ophthalmology & optometrybiology.proteinsense organsDisease SusceptibilityAntibodylcsh:RC581-607businessmicroarrayBiomarkersGlaucoma Open-AngleFrontiers in Immunology
researchProduct

The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma

2018

Purpose: While recent studies described the role of IKZF1/3 proteins in multiple myeloma (MM) cells, few have highlighted the significance of IKZF1/3 expression in T-cells. In this study we examine the prognostic and predictive value of IKZF1/3 expression in T-cells in patients with MM stage III. Experimental design: We analysed the IKZF1/3 expression levels in T-cells from 45 MM stage I (MMI) and 50 newly diagnosed MM stage III (MMIII) patients, according to Durie-Salmon staging system, by flow cytometry to examine their prognostic and predictive value. We also combined in vivo observations with in vitro assays to determine the effect of IKZF1/3 expression on the T-cell immunophenotype and…

lcsh:Immunologic diseases. Allergy0301 basic medicineOncologymedicine.medical_specialtyImmunologyMedizinlcsh:RC254-282Flow cytometry03 medical and health sciencesikzf10302 clinical medicineImmunophenotypingikzf3immunomodulatory drugsIn vivoInternal medicinemedicineImmunology and AllergyStage (cooking)t cellsMultiple myelomaOriginal ResearchLenalidomidemedicine.diagnostic_testbusiness.industrylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasePomalidomidemultiple myelomaThalidomide030104 developmental biologyOncologybiomarker trialsimmunelcsh:RC581-607business030215 immunologymedicine.drug
researchProduct

Autoantigens in the trabecular meshwork and glaucoma‐specific alterations in the natural autoantibody repertoire

2019

Abstract Objectives Primary open‐angle glaucoma (POAG) is a neurodegenerative disorder leading to a gradual vision loss caused by progressive damage to the optic nerve. Immunological processes are proposed to be involved in POAG pathogenesis. Altered serological autoantibody levels have been frequently reported, but complete analyses of the natural autoantibodies with respect to disease‐related alterations are scarce. Here, we provide an explorative analysis of pathways and biological processes that may involve naturally immunogenic proteins and highlight POAG‐specific alterations. Methods Mass spectrometry‐based antibody‐mediated identification of autoantigens (MS‐AMIDA) was carried out in…

lcsh:Immunologic diseases. Allergy0301 basic medicinegenetic structuresImmunologyGlaucomaPDGFRBBiologymedicine.disease_causeAutoimmunityPathogenesis03 medical and health sciences0302 clinical medicineAntigenmedicineImmunology and AllergyGeneral Nursingtrabecular meshworkAutoantibodymedicine.diseaseimmunoproteomicsautoantigeneye diseasesglaucoma030104 developmental biologymedicine.anatomical_structureImmunologybiomarkerBiomarker (medicine)Original Articlenatural autoantibodiessense organsTrabecular meshworklcsh:RC581-607030217 neurology & neurosurgeryClinical & Translational Immunology
researchProduct

Immunological Monitoring to Rationally Guide AAV Gene Therapy

2013

Recent successes with adeno-associated virus (AAV)-based gene therapies fuel the hope for new treatments for hereditary diseases. Pre-existing as well as therapy-induced immune responses against both AAV and the encoded transgenes have been described and may impact on safety and efficacy of gene-therapy approaches. Consequently, monitoring of vector- and transgene-specific immunity is mandated and may rationally guide clinical development. Next to the humoral immune response, the cellular response is central in our understanding of the host reaction in gene therapy. But in contrast to the monitoring of antibodies, which has matured over many decades, sensitive and robust monitoring of T cel…

lcsh:Immunologic diseases. AllergyGenetic enhancementTransgeneImmunologyadeno-associated virus (AAV)Review Articleadeno-associated virusBioinformaticsmedicine.disease_causeImmune systemImmunityNeed to knowimmunological monitoringmedicineImmunology and Allergyassay harmonizationVector (molecular biology)Adeno-associated virusbiologybusiness.industrybiomarkersgene therapybiology.proteinAntibodylcsh:RC581-607businessFrontiers in Immunology
researchProduct

Mucins as a New Frontier in Pulmonary Fibrosis

2019

Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pulmonary disease with a median survival of 3–5 years after diagnosis. Recent evidence identifies mucins as key effectors in cell growth and tissue remodeling processes compatible with the processes observed in IPF. Mucins are classified in two groups depending on whether they are secreted (secreted mucins) or tethered to cell membranes (transmembrane mucins). Secreted mucins (MUC2, MUC5AC, MUC5B, MUC6-8 and MUC19) are released to the extracellular medium and recent evidence has shown that a promoter polymorphism in the secreted mucin MUC5B is associated with IPF risk. Otherwise, transmembrane mucins (MUC1, MUC3,…

lcsh:MedicineContext (language use)Review03 medical and health sciencesIdiopathic pulmonary fibrosis0302 clinical medicinePulmonary fibrosisExtracellularMedicineMUC1030304 developmental biology0303 health sciencesMetalloproteinasebusiness.industryMucinlcsh:RbiomarkersGeneral Medicinemucinsrespiratory systemmedicine.diseaserespiratory tract diseasesIntracellular signal transduction030220 oncology & carcinogenesisCancer researchidiopathic pulmonary fibrosis (IPF)businessJournal of Clinical Medicine
researchProduct

Usefulness of biomarkers as intermediate endpoints in health risks posed by occupational lead exposure

2015

The article concerns potential harmful effects of exposure to lead. Although the occurrence of severe lead poisoning has receded in several countries, occupational exposure resulting in moderate and clinically symptomatic toxicity is still common. An earlier and precise characterization of an individual response is obligatory in order to assess the possible risks for human health. Biomarkers may fill important gaps in the path from exposure to a disease. Specifically speaking, emerging (DNA double strand breaks and telomeric DNA erosion) and validated (micronuclei induction and chromosomal aberrations) biomarkers of genotoxicity seem to provide evidence for the assessment of molecular and c…

lcsh:MedicineDiseaseBioinformaticsmedicine.disease_causeLead poisoningOccupational ExposureEnvironmental healthmedicineHumansDouble strandhealth riskMicronucleus Testsbusiness.industryindividual susceptibilitylcsh:RPublic Health Environmental and Occupational HealthGeneral Medicinemedicine.diseaseOccupational DiseasesLeadLead exposureMicronucleus testOccupational exposureBiomarkers of exposure assessmentbusinessgenotoxic effectsBiomarkersGenotoxicityDNA DamageInternational Journal of Occupational Medicine and Environmental Health
researchProduct

Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease

2021

Inflammatory bowel disease (IBD) is a relapsing chronic disorder of the gastrointestinal tract characterized by disruption of epithelial barrier function and excessive immune response to gut microbiota. The lack of biomarkers providing early diagnosis or defining the status of the pathology difficulties an accurate assessment of the disease. Given the different metabolomic profiles observed in IBD patients, metabolomics may reveal prime candidates to be studied, which may help in understanding the pathology and identifying novel therapeutic targets. In this review, we summarize the most current advances describing the promising metabolites such as lipids or amino acids found through untarge…

lcsh:MedicineReviewDiseaseGut floraBioinformaticsInflammatory bowel disease03 medical and health sciences0302 clinical medicineMetabolomicsImmune systeminflammatory bowel diseaseBiopsymedicine030304 developmental biology0303 health sciencesGastrointestinal tractbiologymedicine.diagnostic_testbusiness.industrylcsh:RbiomarkersGeneral Medicinebiology.organism_classificationmedicine.diseasemetabolomicsPotential biomarkers030211 gastroenterology & hepatologybusinessJournal of Clinical Medicine
researchProduct

‘bien entendu’ vs ‘naturellement’: deux façons de désubjectiviser le dire

2011

Our study focuses on how the discourse markers (DM) participate in the construction of discursive alterity. In our approach, the DM builds, for an assertion, a guarantor with its own semantics, which is the semantics of the lexical element constituting the basis of DM. Naturellement and bien entendu build referential value which ”disempowers” the speaker as a guarantor of his words. This desubjectivation is realized differently in each case analyzed, and is determined by the semantic identity of the DM. In this article we analyze how the DM build modulated commitment of the speaker in his role as the guarantor, convened by the semantics of the DM in the ”disresponsibilization” of the speake…

lcsh:P101-410AlterityAssertionIdentity (social science)SociologySemanticsValue (semiotics)HumanitiesDiscourse markerLinguisticslcsh:Language. Linguistic theory. Comparative grammarOslo Studies in Language
researchProduct

Lead Excretion in Spanish Children with Autism Spectrum Disorder

2015

Among epigenetic factors leading to increased prevalence of juvenile neuropsychiatric disorders, including autism spectrum disorder, exposure to metals, such as lead (Pb) have led to conflicting results. The aim of the present study was to determine the levels of Pb in the urine of children with autism spectrum disorder (ASD) compared with typically developing children (TD) age- and sex-matched, and to analyze any association between core symptoms of ASD, special diets, supplements intake or prescription drugs and the concentration of Pb. The study was performed in a group of children with ASD (n = 35, average age 7.4 ± 0.5 years) and TD (n = 34, average age 7.7 ± 0.9 years). Measurement of…

leadPediatricsmedicine.medical_specialtyGeneral NeuroscienceConfoundingDMS IVautism spectrum disorderUrinecore symptomsmedicine.diseaseArticlelcsh:RC321-571ExcretionAutism spectrum disordermental disordersmedicinebiomarkerStatistical analysisCore symptomsLead (electronics)Psychologylcsh:Neurosciences. Biological psychiatry. NeuropsychiatryClinical evaluationBrain Sciences
researchProduct

Immune-Biomarkers in Advanced Non-Small Cell Lung Cancer

2021

N.A Background: Developing personalized immunotherapy-based approaches, through the identification of predictive immune-related biomarkers, is still a main topic for translational lung cancer research. In the present study we investigated whether baseline tissue “immune-related gene signatures”, as well as plasma chemo-cytokines profiles, could predict sensitivity/resistance to immune-checkpoint inhibitors in pre-treated patients with advanced non-small cell lung cancer (NSCLC). Methods: From September 2015 to September 2018, 150 patients with previously treated advanced NSCLC who received either anti-PD1 or anti-PD-L1 inhibitors in the second-third line setting were included within this tr…

liquid biopsySettore MED/06 - Oncologia MedicaLung CancerbiomarkerImmunotherapyNSCLC
researchProduct